BIOLIFE SOLUTIONS INC
BLFS
DELAYED 1 MONTH

11 insider filings · Latest: Jun 8, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 21, 2026May 21 11:10 PMCasdin Partners Master Fund, L.P.10% Owner
Sale
650,000$23.70$15.4M4,757,165(I)

View →

May 20, 2026May 21 11:10 PMCasdin Partners Master Fund, L.P.10% Owner
Sale
250,000$23.70$5.9M5,407,165(I)

View →

May 19, 2026May 21 11:10 PMCasdin Partners Master Fund, L.P.10% Owner
Sale
300,000$22.65$6.8M5,657,165(I)

View →

Mar 9, 2026Mar 9 10:11 PMKaren A. FosterChief Quality and Operations
Sale
500$20.00$10.0K113,242(D)

View →

Mar 5, 2026Mar 9 10:11 PMKaren A. FosterChief Quality and Operations
Sale
96,923$20.15$2.0M113,742(D)

View →

Mar 3, 2026Mar 5 10:10 PMSean WernerChief Technology Officer
Sale
111$20.74$2.3K49,932(D)

View →

Mar 3, 2026Mar 5 10:10 PMKaren A. FosterChief Quality and Operations
Sale
418$20.74$8.7K210,665(D)

View →

Mar 3, 2026Mar 5 10:10 PMAby J. MathewEVP & Chief Scientific Officer
Sale
529$20.74$11.0K392,937(D)

View →

Mar 3, 2026Mar 5 10:10 PMTroy WichtermanChief Financial Officer
Sale
588$20.74$12.2K220,649(D)

View →

Mar 3, 2026Mar 5 10:10 PMSarah AebersoldChief Human Resources Officer
Sale
219$20.74$4.5K93,360(D)

View →

Mar 3, 2026Mar 5 10:10 PMTodd BerardChief Marketing Officer
Sale
353$20.74$7.3K165,940(D)

View →

Stock Options & Derivatives

No transactions found.